H. B. Fuller (NYSE:FUL) Stock Rating Upgraded by JPMorgan Chase & Co.

H. B. Fuller (NYSE:FUL) was upgraded by stock analysts at JPMorgan Chase & Co. from an “underweight” rating to a “neutral” rating in a note issued to investors on Wednesday. The brokerage presently has a $58.00 price target on the specialty chemicals company’s stock. JPMorgan Chase & Co.‘s price objective indicates a potential downside of 4.51% from the company’s previous close.

Several other analysts also recently commented on FUL. Vertical Research raised shares of H. B. Fuller from a “hold” rating to a “strong-buy” rating in a research report on Friday, March 27th. Wall Street Zen raised shares of H. B. Fuller from a “hold” rating to a “buy” rating in a research report on Sunday, March 29th. Royal Bank Of Canada set a $58.00 price objective on shares of H. B. Fuller in a research report on Wednesday. Citigroup increased their price objective on shares of H. B. Fuller from $67.00 to $70.00 and gave the company a “buy” rating in a research report on Monday, March 30th. Finally, UBS Group set a $58.00 price objective on shares of H. B. Fuller in a research report on Wednesday. One equities research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $63.80.

H. B. Fuller Stock Up 5.1%

FUL stock opened at $60.74 on Wednesday. H. B. Fuller has a twelve month low of $48.71 and a twelve month high of $68.63. The company has a quick ratio of 1.15, a current ratio of 1.92 and a debt-to-equity ratio of 1.01. The business has a 50 day moving average of $59.48 and a 200 day moving average of $60.47. The firm has a market cap of $3.31 billion, a PE ratio of 20.05, a price-to-earnings-growth ratio of 0.76 and a beta of 0.95.

H. B. Fuller (NYSE:FUL) last posted its quarterly earnings results on Thursday, March 26th. The specialty chemicals company reported $0.57 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.56 by $0.01. H. B. Fuller had a return on equity of 11.84% and a net margin of 4.62%.The firm had revenue of $770.84 million during the quarter, compared to analyst estimates of $787.77 million. During the same quarter in the previous year, the firm earned $0.54 EPS. H. B. Fuller’s quarterly revenue was down 2.3% compared to the same quarter last year. On average, research analysts forecast that H. B. Fuller will post 4.77 EPS for the current fiscal year.

Insider Buying and Selling at H. B. Fuller

In other H. B. Fuller news, CEO Celeste Beeks Mastin acquired 5,170 shares of the stock in a transaction dated Tuesday, April 7th. The shares were purchased at an average price of $57.08 per share, for a total transaction of $295,103.60. Following the purchase, the chief executive officer directly owned 8,670 shares of the company’s stock, valued at approximately $494,883.60. This trade represents a 147.71% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this link. 1.83% of the stock is owned by company insiders.

Institutional Investors Weigh In On H. B. Fuller

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Dimensional Fund Advisors LP increased its holdings in H. B. Fuller by 5.4% in the 1st quarter. Dimensional Fund Advisors LP now owns 2,608,006 shares of the specialty chemicals company’s stock worth $160,854,000 after acquiring an additional 132,558 shares in the last quarter. Capital World Investors increased its holdings in H. B. Fuller by 0.5% in the 3rd quarter. Capital World Investors now owns 2,583,213 shares of the specialty chemicals company’s stock worth $153,133,000 after acquiring an additional 12,720 shares in the last quarter. Cooke & Bieler LP increased its holdings in H. B. Fuller by 13.3% in the 4th quarter. Cooke & Bieler LP now owns 1,677,674 shares of the specialty chemicals company’s stock worth $99,754,000 after acquiring an additional 196,644 shares in the last quarter. Victory Capital Management Inc. increased its holdings in H. B. Fuller by 5.7% in the 4th quarter. Victory Capital Management Inc. now owns 1,228,068 shares of the specialty chemicals company’s stock worth $73,021,000 after acquiring an additional 66,686 shares in the last quarter. Finally, UBS Group AG increased its holdings in H. B. Fuller by 35.0% in the 4th quarter. UBS Group AG now owns 1,108,261 shares of the specialty chemicals company’s stock worth $65,897,000 after acquiring an additional 287,390 shares in the last quarter. 95.93% of the stock is owned by hedge funds and other institutional investors.

H. B. Fuller Company Profile

H. B. Fuller Company, founded in 1887 and headquartered in St. Paul, Minnesota, is a global adhesives and specialty chemical solutions provider serving a wide array of industries. The company develops, manufactures and markets adhesive technologies, sealants, polymers and related chemical products designed to enhance product performance, sustainability and manufacturing efficiency.

Fuller’s product portfolio spans multiple market segments, including packaging and converting, general industrial assembly, electronics, transportation, hygiene and construction.